Source: Eur Respir J, 51 (6) 1800017; 10.1183/13993003.00017-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Erika Mohr, Jennifer Hughes, Anja Reuter, Laura Trivino Duran, Gabriella Ferlazzo, Johnny Daniels, Virginia De Azevedo, Yulene Kock, Sarah Jane Steele, Amir Shroufi, Serge Ade, Natavan Alikhanova, Guido Benedetti, Jeffrey Edwards, Helen Cox, Jennifer Furin, Petros Isaakidis. Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. Eur Respir J, 51 (6) 1800017; 10.1183/13993003.00017-2018

Member's Comments

No comment yet.

Related content which might interest you: Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study Source: Eur Respir J 2016; 48: 1496-1499 Year: 2016 Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea Source: Eur Respir J, 57 (3) 2003026; 10.1183/13993003.03026-2020 Year: 2021 The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 A retrospective analysis of quinolone prescriptions for tuberculosis in two North Birmingham hospitals Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible? Source: Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017 Year: 2017 Prospective study of mycobacterium tuberculosis drug resistance in Tunisia Source: Eur Respir J 2004; 24: Suppl. 48, 658s Year: 2004 Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study Source: Eur Respir J , 49 (3) 1601429; DOI: 10.1183/13993003.01429-2016 Year: 2017 A prospective study of multiple drug-resistant tuberculosis in Plovdiv region, Bulgaria, 1989–2004 Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 Pediatric multidrug-resistant tuberculosis in Belgium: a nationwide retrospective cohort study. Source: International Congress 2017 – Update on TB: latest news Year: 2017 Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea Source: Eur Respir J, 51 (3) 1702467; 10.1183/13993003.02467-2017 Year: 2018 Latent tuberculosis infection among contacts of patients with multidrug-resistant tuberculosis in New South Wales, Australia Source: ERJ Open Res, 7 (3) 00149-2021; 10.1183/23120541.00149-2021 Year: 2021 Prospective study analysing prevalence of XDR TB in Mumbai, India Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities Source: Eur Respir J, 52 (4) 1800246; 10.1183/13993003.00246-2018 Year: 2018 Resistance of Mycobacterium tuberculosis to the first-line (MDR) and second line (XDR) anti tuberculosis drugs in the south western zone of Nigeria: A- 3 year retrospective study Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Towards the elimination of paediatric tuberculosis in high-income, immigrant-receiving countries: a 25-year conventional and molecular epidemiological case study Source: ERJ Open Res, 4 (2) 00131-2017; 10.1183/23120541.00131-2017 Year: 2018 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Drug-resistant tuberculosis in Turkmenistan: Results of the first nationwide survey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Multidrug-resistant tuberculosis in Eastern Europe: still on the increase? Source: Eur Respir J 2012; 39: 1290-1291 Year: 2012 Population-based study of fluoroquinolone-resistance in clinical isolates of Mycobacterium tuberculosis in Novosibirsk Oblast, Russian Federation Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012